Underrepresentation of sex in reporting traditional and emerging biomarkers for primary prevention of cardiovascular disease: a systematic review

European Heart Journal. Quality of Care & Clinical Outcomes
Aisha GoharHester den Ruijter

Abstract

Primary prevention of cardiovascular disease (CVD) relies on the identification of individuals at increased risk of developing cardiovascular events. Circulating biomarkers mirroring the (subclinical) disease process are valuable tools for CVD risk prediction. Evidence is accumulating that the clinical presentation and mechanisms for CVD differ between men and women. A systematic review of sex-specific data was performed on biomarker levels and their association with CVD in primary prevention in order to investigate the availability of sex-specific data and to explore for any differences in the associations between men and women. PubMed MEDLINE and Embase were searched on 2 February 2014 and updated on 15 January 2015. Biomarkers included represented pathophysiological pathways of lipids, inflammation, kidney function, and of the heart. Data on patient characteristics, sex-specific biomarker levels, biomarker association with future CVD events and clinical value were extracted. Only 54 studies of 360 publications provided sex-specific information. Most of the remaining 306 publications not providing sex-specific results only corrected for sex in multivariable models. The additional clinical utility of biomarkers was reported in...Continue Reading

References

Sep 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J Loscalzo
Oct 1, 1996·Journal of the American College of Cardiology·S KinlayJ Dickeson
Dec 19, 1998·Journal of the American College of Cardiology·G DangasJ T Fallon
Jun 13, 2002·Clinical Chemistry and Laboratory Medicine : CCLM·Aldo ClericoDaniela Giannessi
Dec 3, 2003·The New England Journal of Medicine·Abraham A AriyoUNKNOWN Cardiovascular Health Study Investigators
May 6, 2006·Stroke; a Journal of Cerebral Circulation·Tetsuya OhiraAaron R Folsom
Feb 1, 2007·Journal of Vascular Surgery·Willem E HellingsFrans L Moll
Jan 8, 2008·Health Care for Women International·Leila Gholizadeh, Patricia Davidson
Mar 20, 2010·Journal of the American College of Cardiology·Jeffrey S BergerRoger S Blumenthal
Jul 29, 2010·Cerebrovascular Diseases·Bernadette Boden-AlbalaLars Berglund
Dec 9, 2010·JAMA : the Journal of the American Medical Association·James A de LemosDarren K McGuire
Jul 21, 2012·Journal of the American College of Cardiology·Anna ZampetakiManuel Mayr
Dec 12, 2012·Annals of Neurology·Peter Brøndum-JacobsenMarianne Benn
Dec 25, 2012·Thrombosis Research·Shizukiyo IshikawaUNKNOWN Jichi Medical School (JMS) cohort study group
Aug 1, 2014·Heart·Maria F HughesUNKNOWN FINRISK and BiomarCaRE investigators
Sep 23, 2014·Journal of cardiology·Kaffer KaraAmir Abbas Mahabadi
Dec 19, 2014·Circulation·Dariush MozaffarianUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Aug 26, 2017·European Heart Journal. Quality of Care & Clinical Outcomes·Takeo OnoseUNKNOWN CHART-2 Investigators
Apr 1, 2016·European Heart Journal. Quality of Care & Clinical Outcomes·Julie George

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.